Informations:
Erreur:
ID
32134
Description
D-serine Monotherapy for Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00816894
Lien
https://clinicaltrials.gov/show/NCT00816894
Mots-clés
Versions (1)
- 20/10/2018 20/10/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
20 octobre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Schizophrenia NCT00816894
Eligibility Schizophrenia NCT00816894
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00816894
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Age
Item
1. age 18-70;
boolean
C0001779 (UMLS CUI [1])
Schizophrenia | Schizoaffective Disorder
Item
2. diagnosis of schizophrenia/schizoaffective disorder according to dsm-iv criteria.
boolean
C0036341 (UMLS CUI [1])
C0036337 (UMLS CUI [2])
C0036337 (UMLS CUI [2])
Antipsychotic drug therapy Dose Stable
Item
3. stable dose antipsychotic treatment for at least 4 weeks;
boolean
C1319421 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Unresponsive to Treatment
Item
4. treatment refractoriness according to kane et al.(1988) criteria.
boolean
C0205269 (UMLS CUI [1])
Axis I diagnosis Other
Item
1. meeting criteria for other dsm-iv axis i diagnoses ;
boolean
C0270287 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,2])
Substance Use Disorders Lifetime | Chronic Alcoholic Intoxication Lifetime
Item
2. substance abuse or alcoholism during entire lifetime;
boolean
C0038586 (UMLS CUI [1,1])
C4071830 (UMLS CUI [1,2])
C0001973 (UMLS CUI [2,1])
C4071830 (UMLS CUI [2,2])
C4071830 (UMLS CUI [1,2])
C0001973 (UMLS CUI [2,1])
C4071830 (UMLS CUI [2,2])
At risk for suicide | At risk Homicide
Item
3. are judged clinically to be at suicidal or homicidal risk;
boolean
C0563664 (UMLS CUI [1])
C1444641 (UMLS CUI [2,1])
C0019872 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,1])
C0019872 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Gender Sexually active Contraceptive methods
Item
4. female patients who are pregnant or lactating; female patients who are not pregnant or lactating, if sexually active, must be using medically accepted means of contraception;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0241028 (UMLS CUI [3,2])
C0700589 (UMLS CUI [3,3])
Intolerance to Olanzapine | Olanzapine High dose failed
Item
5. patients with known intolerance to ola treatment or who have failed an adequate trial of ola (at least 6 weeks) at high doses (20 mg/day or higher);
boolean
C1744706 (UMLS CUI [1,1])
C0171023 (UMLS CUI [1,2])
C0171023 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
C0171023 (UMLS CUI [1,2])
C0171023 (UMLS CUI [2,1])
C0444956 (UMLS CUI [2,2])
C0231175 (UMLS CUI [2,3])
Injection of depot antipsychotic agent | Electroconvulsive Therapy
Item
6. patients treated with depot antipsychotics or ect within the eight weeks prior to study entry.
boolean
C2585377 (UMLS CUI [1])
C0013806 (UMLS CUI [2])
C0013806 (UMLS CUI [2])